TGTX
Tg Therapeutics Inc Earnings
$31.36
Earnings Summary
Revenue | $161.71Mn |
Net Profits | $390.9Mn |
Net Profit Margins | 241.73% |
Tg Therapeutics Inc’s revenue jumped 92.79% since last year same period to $161.71Mn in the Q3 2025. On a quarterly growth basis, Tg Therapeutics Inc has generated 14.57% jump in its revenue since last 3-months.
Tg Therapeutics Inc’s net profit jumped 9974.61% since last year same period to $390.9Mn in the Q3 2025. On a quarterly growth basis, Tg Therapeutics Inc has generated 1286.79% jump in its net profits since last 3-months.
Tg Therapeutics Inc’s net profit margin jumped 5125.74% since last year same period to 241.73% in the Q3 2025. On a quarterly growth basis, Tg Therapeutics Inc has generated 1110.46% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | 0.25 |
EPS Estimate Current Year | 0.25 |
Tg Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at 0.25 - a 33.79% jump from last quarter’s estimates.
Tg Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at 0.25.
Key Ratios
Earning Per Share (EPS) | 0 |
Tg Therapeutics Inc’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Tg Therapeutics Inc has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-05-09 | 0.17 | 0.03 | -82.76% |
2025-08-08 | 0.19 | 0.17 | -10.53% |
2025-09-30 | 0.25 | 0 | -100% |
